HSCL — Himadri Speciality Chemical Balance Sheet
0.000.00%
- IN₹195.85bn
- IN₹194.26bn
- IN₹41.85bn
Annual balance sheet for Himadri Speciality Chemical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 463 | 1,374 | 2,647 | 6,244 | 7,319 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,157 | 4,894 | 5,223 | 5,420 | 7,021 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,364 | 10,474 | 16,681 | 18,851 | 23,070 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16,316 | 16,261 | 16,214 | 16,080 | 15,997 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 25,624 | 27,912 | 34,538 | 36,781 | 44,488 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,429 | 8,413 | 14,124 | 12,476 | 12,030 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 8,283 | 9,983 | 15,862 | 13,976 | 14,032 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 17,342 | 17,929 | 18,676 | 22,805 | 30,456 |
Total Liabilities & Shareholders' Equity | 25,624 | 27,912 | 34,538 | 36,781 | 44,488 |
Total Common Shares Outstanding |